Submitted by Anonymous (not verified) on 19 November 2024 - 14:00
Orphan designation: Marstacimab Treatment of haemophilia B, 13/12/2023 Withdrawn
Source:
Orphan designation: Marstacimab Treatment of haemophilia B, 13/12/2023 Withdrawn